BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
healthcare glob. ent. ltd stock

HEALTHCARE GLOB. ENT. LTD Share Price

495 -9.45 (-1.87%)
Dec 12 2024 03:29 PM Healthcare NSE: HCG

HEALTHCARE GLOB. ENT. LTD Share Price Update

As of the latest trading session, HEALTHCARE GLOB. ENT. LTD share price is currently at 495, which is down by -9.45 from its previous closing. Today, the stock has fluctuated between 493.10 and 507.00. Over the past year, HEALTHCARE GLOB. ENT. LTD has achieved a return of 38.22 %. In the last month alone, the return has been 8.51 %. Read More...

HEALTHCARE GLOB. ENT. LTD Performance

Day Range

Low493.10 High507.00
495.40

52 Week Range

Low 314.00 High 519.50
495.40

HEALTHCARE GLOB. ENT. LTD Share Price

15555

539787

HCG

img img img img
No Data Available

Open Price

507.00

Prev. Close

504.45

Volume (Shares)

94548.00

Total traded value

468.39

Upper Circuit

605.30

Lower Circuit

403.60

Note: The current prices & values are delayed, Login to your account for live updates.

HEALTHCARE GLOB. ENT. LTD Fundamentals


(Standalone)

Market Cap (Cr) 6894.83
PE Ratio (TTM) 205.16
Book Value / Share 87.62
Beta 0.49
ROE 3.22%
EPS (TTM) 3.15
Dividend Yield 0.00%
Net Profit Qtr (Cr) 16.03

HEALTHCARE GLOB. ENT. LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 305.96
Operating Expense 295.92
Net Profit 16.03
Net Profit Margin (%) 5.23
Earnings Per Share (EPS) 1.15
EBITDA 68.28
Effective Tax Rate (%) 23.63
Particulars JUN 2024 (Values in Cr)
Revenue 292.94
Operating Expense 288.90
Net Profit 11.72
Net Profit Margin (%) 4.00
Earnings Per Share (EPS) 0.84
EBITDA 60.39
Effective Tax Rate (%) 22.94
Particulars MAR 2024 (Values in Cr)
Revenue 279.27
Operating Expense 264.81
Net Profit -1.76
Net Profit Margin (%) -0.63
Earnings Per Share (EPS) -0.13
EBITDA 42.87
Effective Tax Rate (%) 149.02
Particulars DEC 2023 (Values in Cr)
Revenue 266.50
Operating Expense 257.78
Net Profit 8.33
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 0.60
EBITDA 52.25
Effective Tax Rate (%) 44.28
Particulars SEP 2023 (Values in Cr)
Revenue 282.00
Operating Expense 266.60
Net Profit 13.70
Net Profit Margin (%) 4.85
Earnings Per Share (EPS) 0.98
EBITDA 52.54
Effective Tax Rate (%) 25.05
Particulars MAR 2024 (Values in Cr)
Revenue 1099.29
Operating Expense 1045.21
Net Profit 33.96
Net Profit Margin (%) 3.08
Earnings Per Share (EPS) 2.44
EBITDA 197.03
Effective Tax Rate (%) 38.09
Particulars MAR 2023 (Values in Cr)
Revenue 1005.57
Operating Expense 955.77
Net Profit 40.19
Net Profit Margin (%) 3.99
Earnings Per Share (EPS) 2.89
EBITDA 188.07
Effective Tax Rate (%) 30.24
Particulars MAR 2022 (Values in Cr)
Revenue 849.83
Operating Expense 834.12
Net Profit 38.25
Net Profit Margin (%) 4.50
Earnings Per Share (EPS) 2.95
EBITDA 212.20
Effective Tax Rate (%) 52.80
Particulars MAR 2021 (Values in Cr)
Revenue 608.86
Operating Expense 684.83
Net Profit -191.54
Net Profit Margin (%) -31.45
Earnings Per Share (EPS) -15.28
EBITDA -55.61
Effective Tax Rate (%) 6.58
Particulars MAR 2020 (Values in Cr)
Revenue 688.33
Operating Expense 735.00
Net Profit -53.30
Net Profit Margin (%) -7.74
Earnings Per Share (EPS) -6.02
EBITDA 96.94
Effective Tax Rate (%) 18.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 59.28
ROE % 3.14
ROCE % 7.19
Total Debt to Total Equity 1.29
EBITDA Margin 18.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.86
ROE % 1.35
ROCE % 6.56
Total Debt to Total Equity 1.05
EBITDA Margin 18.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.61
ROE % -0.62
ROCE % 4.62
Total Debt to Total Equity 1.21
EBITDA Margin 17.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 52.11
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.16
EBITDA Margin 14.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 42.99
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.34
EBITDA Margin 15.27
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.33
ROE % 3.22
ROCE % 6.23
Total Debt to Total Equity 0.47
EBITDA Margin 19.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share 82.31
ROE % 3.07
ROCE % 5.85
Total Debt to Total Equity 0.31
EBITDA Margin 18.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 78.96
ROE % 1.19
ROCE % 4.55
Total Debt to Total Equity 0.41
EBITDA Margin 18.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 70.19
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.85
EBITDA Margin 16.02
Particulars MAR 2020 (Values in Cr)
Book Value / Share 69.29
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.99
EBITDA Margin 18.56
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 303.07
Total Assets 2707.49
Total Liabilities 2707.49
Total Equity 865.11
Share Outstanding 139289687
Price to Book Ratio 3.96
Return on Assets (%) 1.77
Return on Capital (%) 3.13
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 196.63
Total Assets 2316.01
Total Liabilities 2316.01
Total Equity 869.41
Share Outstanding 139116062
Price to Book Ratio 3.19
Return on Assets (%) 1.26
Return on Capital (%) 2.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 197.50
Total Assets 2219.52
Total Liabilities 2219.52
Total Equity 883.71
Share Outstanding 139011992
Price to Book Ratio 3.42
Return on Assets (%) 2.42
Return on Capital (%) 4.16
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 40.85
Total Assets 2035.61
Total Liabilities 2035.61
Total Equity 714.00
Share Outstanding 125359284
Price to Book Ratio 2.72
Return on Assets (%) -9.50
Return on Capital (%) -16.32
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 32.01
Total Assets 2253.17
Total Liabilities 2253.17
Total Equity 419.76
Share Outstanding 88690629
Price to Book Ratio 1.08
Return on Assets (%) -4.73
Return on Capital (%) -10.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 237.33
Total Assets 2187.89
Total Liabilities 2187.89
Total Equity 1188.58
Share Outstanding 139289687
Price to Book Ratio 3.96
Return on Assets (%) 1.55
Return on Capital (%) 2.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 80.36
Total Assets 1729.70
Total Liabilities 1729.70
Total Equity 1145.12
Share Outstanding 139116062
Price to Book Ratio 3.19
Return on Assets (%) 2.32
Return on Capital (%) 3.17
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 119.95
Total Assets 1643.61
Total Liabilities 1643.61
Total Equity 1097.69
Share Outstanding 139011992
Price to Book Ratio 3.42
Return on Assets (%) 2.32
Return on Capital (%) 3.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.46
Total Assets 1574.51
Total Liabilities 1574.51
Total Equity 923.78
Share Outstanding 125359284
Price to Book Ratio 2.72
Return on Assets (%) -12.16
Return on Capital (%) -16.47
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 15.13
Total Assets 1768.91
Total Liabilities 1768.91
Total Equity 614.50
Share Outstanding 88690629
Price to Book Ratio 1.08
Return on Assets (%) -3.01
Return on Capital (%) -5.16
Particulars MAR 2024 (Values in Cr)
Net Income 67.72
Cash from Operations 331.94
Cash from Investing -225.72
Cash from Financing -64.01
Net change in Cash -5.16
Free Cash Flow 517.62
Particulars MAR 2023 (Values in Cr)
Net Income 44.88
Cash from Operations 274.30
Cash from Investing -133.03
Cash from Financing -140.06
Net change in Cash -21.50
Free Cash Flow 407.54
Particulars MAR 2022 (Values in Cr)
Net Income 87.77
Cash from Operations 243.82
Cash from Investing 124.58
Cash from Financing -154.88
Net change in Cash 189.82
Free Cash Flow 315.05
Particulars MAR 2021 (Values in Cr)
Net Income -228.66
Cash from Operations 82.55
Cash from Investing -171.10
Cash from Financing 112.24
Net change in Cash 61.65
Free Cash Flow 117.97
Particulars MAR 2020 (Values in Cr)
Net Income -119.26
Cash from Operations 156.85
Cash from Investing -101.38
Cash from Financing -58.42
Net change in Cash -29.67
Free Cash Flow 264.66
Particulars MAR 2024 (Values in Cr)
Net Income 54.86
Cash from Operations 227.83
Cash from Investing -249.19
Cash from Financing 105.36
Net change in Cash 50.87
Free Cash Flow 352.64
Particulars MAR 2023 (Values in Cr)
Net Income 57.62
Cash from Operations 147.64
Cash from Investing -137.70
Cash from Financing -41.71
Net change in Cash -49.02
Free Cash Flow 249.76
Particulars MAR 2022 (Values in Cr)
Net Income 81.04
Cash from Operations 139.11
Cash from Investing 48.64
Cash from Financing -41.04
Net change in Cash 132.00
Free Cash Flow 181.56
Particulars MAR 2021 (Values in Cr)
Net Income -205.05
Cash from Operations 30.45
Cash from Investing -245.62
Cash from Financing 235.92
Net change in Cash 61.18
Free Cash Flow 53.38
Particulars MAR 2020 (Values in Cr)
Net Income -65.46
Cash from Operations 106.21
Cash from Investing -115.99
Cash from Financing -2.75
Net change in Cash -32.41
Free Cash Flow 186.51
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 89.24 14.08 105571.01 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.99 0.00 3.95 118.05 44.00 / 107.94
SHREE PACETRONIX LTD. 121.20 19.52 3.24 43.62 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.66 0.00 5.35 58.04 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 94.01 12.88 105571.01 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 54.13 0.00 -28.99 40.44 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5427.00 29.43 6.09 5937.14 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 504.20
  • 26 Days 486.30
  • 10 Days 504.00
  • 50 Days 468.60
  • 12 Days 499.30
  • 100 Days 435.40
  • 20 Days 491.90
  • 200 Days 379.60
505.77
PIVOT
First Resistance 511.13
Second Resistance 517.82
Third Resistance 523.18
First Support 499.08
Second Support 493.72
Third Support 487.03
RSI 67.56
MACD 13.02
Commodity Channel Index (CCI) 71.44
ADX 55.87
Williams % R -19.58

Over 1 Month

down

8.51

Over 3 Months

down

20.95

Over 6 Months

down

36.46

Over 1 Year

down

38.22

Over 3 Years

down

24.81

Over 5 Years

down

40.42

HEALTHCARE GLOB. ENT. LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

HEALTHCARE GLOB. ENT. LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
9.74
Promoter Holdings
71.23
FII
4.29
DII
11.64
Promoter Shares(Pledge Percentage)
3.09
Name Category Shares Shares%
Aceso Company Pte. Ltd. Shareholding of Promoter and Promoter Group 8.4134078E7 60.36
Ajaikumar B S Shareholding of Promoter and Promoter Group 1.4498715E7 10.4
Tata Mutual Fund - Tata Small Cap Fund Public Shareholding 4672362.0 3.35
Nippon Life India Trustee Ltd-a/c Nippon India Els Public Shareholding 4400432.0 3.16
International Finance Corporation Public Shareholding 3259162.0 2.34
Icici Prudential Pharma Healthcare And Diaganostic Public Shareholding 3030561.0 2.17
Clarus Capital I Public Shareholding 2379003.0 1.71
Asmitha Ajaikumar Shareholding of Promoter and Promoter Group 327259.0 0.23
Aagnika Ajaikumar Shareholding of Promoter and Promoter Group 327258.0 0.23
Anjali Ajaikumar Rossi Shareholding of Promoter and Promoter Group 1000.0 0.0
Bhagya A Ajaikumar Shareholding of Promoter and Promoter Group 1795.0 0.0

HEALTHCARE GLOB. ENT. LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About HEALTHCARE GLOB. ENT. LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by HEALTHCARE GLOB. ENT. LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Healthcare Global Enterprises Ltd?

Answer Field

The share price of Healthcare Global Enterprises Ltd for NSE is ₹ 495 and for BSE is ₹ 494.8.

What is the Market Cap of Healthcare Global Enterprises Ltd?

Answer Field

The market cap of Healthcare Global Enterprises Ltd for NSE is ₹ 68,94.83 Cr. and for BSE is ₹ 68,92.05 Cr. as of now.

What is the 52 Week High and Low of Healthcare Global Enterprises Ltd?

Answer Field

The 52 Week High and Low of Healthcare Global Enterprises Ltd for NSE is ₹ 519.50 and ₹ 314.00 and for BSE is ₹ 515.50 and ₹ 310.10.

How to Buy Healthcare Global Enterprises Ltd share?

Answer Field

You can trade in Healthcare Global Enterprises Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Healthcare Global Enterprises Ltd?

Answer Field

The 1 year returns on the stock has been 38.22%.

What is the Current Share Price of Healthcare Global Enterprises Ltd?

Answer Field

Healthcare Global Enterprises Ltd share price is for NSE ₹ 495 & for BSE ₹ 494.8 as on Dec 12 2024 03:29 PM.

What is the Market Cap of Healthcare Global Enterprises Ltd Share?

Answer Field

The market cap of Healthcare Global Enterprises Ltd for NSE ₹ 68,94.83 & for BSE ₹ 68,92.05 as on Dec 12 2024 03:29 PM.

What is the P/E Ratio of Healthcare Global Enterprises Ltd Share?

Answer Field

As on Dec 12 2024 03:29 PM the price-to-earnings (PE) ratio for Healthcare Global Enterprises Ltd share is 205.16.

What is the PB ratio of Healthcare Global Enterprises Ltd Share?

Answer Field

As on Dec 12 2024 03:29 PM, the price-to-book (PB) ratio for Healthcare Global Enterprises Ltd share is 87.62.

How to Buy Healthcare Global Enterprises Ltd Share?

Answer Field

You can trade in Healthcare Global Enterprises Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Healthcare Global Enterprises Ltd Share on Bajaj Broking App?

Answer Field

To buy Healthcare Global Enterprises Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Healthcare Global Enterprises Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader